142
Views
15
CrossRef citations to date
0
Altmetric
Review

Portal vein embolization: rationale, outcomes, controversies and future directions

, &
Pages 489-501 | Published online: 10 Jan 2014

References

  • Tsao JI, Loftus JP, Nagorney DM, Adson MA, Ilstrup DM. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann. Surg.220, 199–205 (1994).
  • Shirabe K, Shimada M, Gion T et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J. Am. Coll. Surg.188, 304–309 (1999).
  • Vauthey JN, Chaoui A, Do KA et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery127, 512–519 (2000).
  • Shoup M, Gonen M, D’Angelica M et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J. Gastrointest. Surg.7, 325–330 (2003).
  • Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch. Surg.137, 675–680 (2002).
  • Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology26, 1176–1181 (1997).
  • Azoulay D, Castaing D, Smail A et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann. Surg.231, 480–486 (2000).
  • Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br. J. Surg.88, 165–175 (2001).
  • Makuuchi M, Thai BL, Takayasu K et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery107, 521–527 (1990).
  • de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology24, 1386–1391 (1996).
  • Nagino M, Nimura Y, Kamiya J et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery117, 677–681 (1995).
  • Nagino M, Kamiya J, Kanai M et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery127, 155–160 (2000).
  • Vauthey JN, Abdalla EK, Doherty DA et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl.8, 233–240 (2002).
  • Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J. Vasc. Interv. Radiol.16, 779–790 (2005).
  • Vauthey JN, Pawlik TM, Abdalla EK et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann. Surg.239, 722–730 (2004).
  • Black DM, Behrns KE. A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration. Surg. Oncol. Clin. N. Am.11, 849–864 (2002).
  • Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration. J. Am. Coll. Surg.197, 634–659 (2003).
  • Michalopoulos GK, DeFrances MC. Liver regeneration. Science276, 60–66 (1997).
  • Bucher NL, Swaffield MN. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res.24, 1611–1625 (1964).
  • Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J. Surg.17, 109–115 (1993).
  • Michalopoulos GK, Zarnegav R. Hepatocyte growth factor. Hepatology15, 149–155 (1992).
  • Goto Y, Nagino M, Nimura Y. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann. Surg.228, 209–213 (1998).
  • Shimamura T, Nakajima Y, Une Y et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery121, 135–141 (1997).
  • Nagino M, Nimura Y, Kamiya J et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology21, 434–439 (1995).
  • Ijichi M, Makuuchi M, Imamura H, Takayama T. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery130, 116–118 (2001).
  • Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann. Surg.223, 77–83 (1996).
  • Hirai I, Kimura W, Fuse A, Suto K, Urayama M. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery133, 495–506 (2003).
  • Imamura H, Shimada R, Kubota M et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology29, 1099–1105 (1999).
  • Wakabayashi H, Okada S, Maeba T, Maeta H. Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg. Today27, 403–410 (1997).
  • Shibayama Y, Hashimoto K, Nakata K. Recovery from hepatic necrosis following acute portal vein embolism with special reference to reconstruction of occluded vessels. J. Pathol.165, 255–261 (1991).
  • Duncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP. Embolization of portal vein branches induces hepatocyte replication in swine: a potential step in hepatic gene therapy. Radiology210, 467–477 (1999).
  • Ikeda K, Kinoshita H, Hirohashi K, Kubo S, Kaneda K. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch. Histol. Cytol.58, 171–184 (1995).
  • Kawarada Y, Sanda M, Kawamura K, Suzaki M, Nakase I, Mizumoto R. Simultaneous extensive resection of the liver and the pancreas in dogs. Gastroenterol. Jpn.26, 747–756 (1991).
  • Elias D, Lasser P, Spielmann M et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg. Gynecol. Obstet.172, 461–464 (1991).
  • Azoulay D, Castaing D, Krissat J et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann. Surg.232, 665–672 (2000).
  • Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg.240, 644–657; discussion 657–648 (2004).
  • Kishi Y, Abdalla EK, Chun YS et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann. Surg. DOI: 10.1097/SLA.?0b013e3181b674df (2009) (Epub ahead of print).
  • Denys AL, De Baere T, Doenz F. Portal vein embolization: a plea for strict patient selection. AJR Am. J. Roentgenol.187, W125 (2006).
  • Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery135, 404–410 (2004).
  • Denys A, Madoff DC, Doenz F et al. Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg. Oncol. Clin. N. Am.11, 955–968 (2002).
  • Madoff DC, Hicks ME, Vauthey JN et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics22, 1063–1076 (2002).
  • Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl.11, 1481–1493 (2005).
  • Chun YS, Ribero D, Abdalla EK et al. Comparison of two methods of future liver remnant volume measurement. J. Gastrointest. Surg.12, 123–128 (2008).
  • Truant S, Oberlin O, Sergent G et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J. Am. Coll. Surg.204, 22–33 (2007).
  • Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J. Surg.10, 803–808 (1986).
  • Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff DC. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin. Intervent. Radiol.25, 132–145 (2008).
  • Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology200, 559–563 (1996).
  • Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness – study in 26 patients. Radiology227, 251–260 (2003).
  • Madoff DC, Abdalla EK, Gupta S et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J. Vasc. Interv. Radiol.16, 215–225 (2005).
  • Gibo M, Unten S, Yogi A et al. Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience. Radiat. Med.25, 164–172 (2007).
  • Tsuda M, Kurihara N, Saito H et al. Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. J. Vasc. Interv. Radiol.17, 989–994 (2006).
  • Azoulay D, Raccuia JS, Castaing D, Bismuth H. Right portal vein embolization in preparation for major hepatic resection. J. Am. Coll. Surg.181, 266–269 (1995).
  • Denys A, Lacombe C, Schneider F et al. Portal vein embolization with n-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J. Vasc. Interv. Radiol.16, 1667–1674 (2005).
  • Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology1, 431–435 (1981).
  • Di Stefano DR, de Baere T, Denys A et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology234, 625–630 (2005).
  • Farges O, Belghiti J, Kianmanesh R et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg.237, 208–217 (2003).
  • Wakabayashi H, Yachida S, Maeba T, Maeta H. Indications for portal vein embolization combined with major hepatic resection for advanced-stage hepatocellular carcinomas. A preliminary clinical study. Dig. Surg.17, 587–594 (2000).
  • Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br. J. Surg.87, 879–882 (2000).
  • Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br. J. Surg.94, 1386–1394 (2007).
  • Elias D, Cavalcanti A, de Baere T, Roche A, Lasser P. [Long-term oncological results of hepatectomy performed after selective portal embolization]. Ann. Chir.53, 559–564 (1999).
  • Abulkhir A, Limongelli P, Healey AJ et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann. Surg.247, 49–57 (2008).
  • Palavecino M, Chun YS, Madoff DC et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery145, 399–405 (2009).
  • Kodama Y, Shimizu T, Endo H, Miyamoto N, Miyasaka K. Complications of percutaneous transhepatic portal vein embolization. J. Vasc. Interv. Radiol.13, 1233–1237 (2002).
  • van Gulik TM, van den Esschert JW, de Graaf W et al. Controversies in the use of portal vein embolization. Dig. Surg.25, 436–444 (2008).
  • Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am. J. Physiol.249, G549–G556 (1985).
  • Barbaro B, Di Stasi C, Nuzzo G, Vellone M, Giuliante F, Marano P. Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol.44, 98–102 (2003).
  • Kokudo N, Tada K, Seki M et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology34, 267–272 (2001).
  • Hayashi S, Baba Y, Ueno K et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol.48, 721–727 (2007).
  • Aoki T, Imamura H, Hasegawa K et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch. Surg.139, 766–774 (2004).
  • Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br. J. Surg.93, 1091–1098 (2006).
  • Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann. Surg. Oncol.15, 2765–2772 (2008).
  • Covey AM, Brown KT, Jarnagin WR et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann. Surg.247, 451–455 (2008).
  • Goere D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J. Gastrointest. Surg.10, 365–370 (2006).
  • Beal IK, Anthony S, Papadopoulou A et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br. J. Radiol.79, 473–478 (2006).
  • Wakabayashi H, Ishimura K, Okano K et al. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer92, 2384–2390 (2001).
  • Broering DC, Hillert C, Krupski G et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J. Gastrointest. Surg.6, 905–913; discussion 913 (2002).
  • Aussilhou B, Lesurtel M, Sauvanet A et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J. Gastrointest. Surg.12, 297–303 (2008).
  • Are C, Iacovitti S, Prete F, Crafa FM. Feasibility of laparoscopic portal vein ligation prior to major hepatectomy. HPB (Oxford)10, 229–233 (2008).
  • Ayiomamitis GD, Low JK, Alkari B, Lee SH, Ammori BJ. Role of laparoscopic right portal vein ligation in planning staged or major liver resection. J. Laparoendosc. Adv. Surg. Tech. A19, 409–413 (2009).
  • Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D. Extension of right portal vein embolization to segment IV portal branches. Arch. Surg.140, 1100–1103 (2005).
  • Kishi Y, Madoff DC, Abdalla EK et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery144, 744–751 (2008).
  • Kang BK, Kim JH, Kim KM et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma after attempted portal vein embolization in 25 patients. AJR Am. J. Roentgenol.193, W446–W451 (2009).
  • Furst G, Schulte am Esch J, Poll LW et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology243, 171–179 (2007).
  • Shimizu H, Takatsuka K, Yoshida A, Yoshimatsu E, Matsui K, Iwabuchi S. Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis. Intern. Med.48, 747–751 (2009).
  • Lainas P, Boudechiche L, Osorio A et al. Liver regeneration and recanalization time course following reversible portal vein embolization. J. Hepatol.49, 354–362 (2008).
  • Dagher I, Nguyen TH, Groyer-Picard MT et al. Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates. Hepatology49, 950–959 (2009).
  • Madoff DC, Gupta S, Pillsbury EP et al. Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine. J. Vasc. Interv. Radiol.18, 79–93 (2007).
  • Kan Z, Wright K, Wallace S. Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad. Radiol.4, 275–282 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.